Voyager Therapeutics, Inc. (VYGR)
USD 5.79
(-7.36%)
USD 5.79
(-7.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 77.91 Million | -12.5 Million | -53.52 Million | -96.71 Million | 48.66 Million | -15.88 Million |
| Net Income | 132.33 Million | -46.4 Million | -71.19 Million | 36.74 Million | -43.59 Million | -88.28 Million |
| Depreciation & Amortization | 4.44 Million | 6.19 Million | 5.16 Million | 3.81 Million | 2.76 Million | 2.11 Million |
| Deferred income taxes | -104.23 Million | - | 349 Thousand | 27 Thousand | -3.58 Million | -2.16 Million |
| Stock-based compensation | 11.15 Million | 9.34 Million | 11.32 Million | 14.93 Million | 15.64 Million | 15.71 Million |
| Change in working capital | -66.55 Million | 20.47 Million | 3.29 Million | -144.53 Million | 78.43 Million | 55.38 Million |
| Other non-cash items | 100.78 Million | -2.1 Million | -2.46 Million | -7.69 Million | -996 Thousand | 1.35 Million |
| Investing Cash Flow | -141.64 Million | -7.33 Million | 65.9 Million | 112.99 Million | -90.47 Million | 26.46 Million |
| Investments in PPE | -3.25 Million | -2.49 Million | -1.6 Million | -12.09 Million | -7.71 Million | -4.3 Million |
| Acquisitions | 138.38 Million | 4.84 Million | -2.46 Million | -7.69 Million | 172 Thousand | - |
| Investment purchases | -223.96 Million | -54.84 Million | -15.11 Million | -70.4 Million | -494.23 Million | -333.22 Million |
| Sales/Maturities of investments | 85.58 Million | 50 Million | 82.63 Million | 195.49 Million | 411.3 Million | 364 Million |
| Other Investing Activities | -138.38 Million | -4.84 Million | 2.46 Million | 7.69 Million | -82.75 Million | 30.77 Million |
| Financing Cash Flow | 33.64 Million | 1.11 Million | 612 Thousand | 3.16 Million | 80.99 Million | 4.74 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 481 Thousand | 584 Thousand | 844 Thousand | 663 Thousand | 860 Thousand |
| Common Stock Issuance | 33.64 Million | 1.11 Million | 612 Thousand | 3.16 Million | 80.99 Million | 4.74 Million |
| Other Financing Activities | 33.64 Million | 1.11 Million | 612 Thousand | 3.16 Million | 80.99 Million | 4.74 Million |
| Accounts receivables | -83.23 Million | 475 Thousand | 7.28 Million | 10.48 Million | -18.49 Million | - |
| Accounts payables | -962 Thousand | 1.99 Million | -60 Thousand | -3.43 Million | 2.59 Million | -282 Thousand |
| Inventory | - | - | -2.2 Million | -909 Thousand | 13.5 Million | - |
| Other working capital | 17.63 Million | 18 Million | -1.72 Million | -150.67 Million | 80.83 Million | 55.66 Million |
| Cash at beginning of period | 98.95 Million | 119.21 Million | 106.21 Million | 86.77 Million | 47.59 Million | 32.26 Million |
| Cash at end of period | 68.8 Million | 100.47 Million | 119.21 Million | 106.21 Million | 86.77 Million | 47.59 Million |
| Capital Expenditure | -3.25 Million | -2.49 Million | -1.6 Million | -12.09 Million | -7.71 Million | -4.3 Million |
| Effect of forex changes on cash | -78 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -30.15 Million | -18.73 Million | 12.99 Million | 19.44 Million | 39.18 Million | 15.32 Million |
| Free Cash Flow | 74.66 Million | -15 Million | -55.13 Million | -108.81 Million | 40.94 Million | -20.19 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.14 Million | -11.33 Million | 56.39 Million | 132.33 Million | -25.9 Million | -22.2 Million |
| Depreciation & Amortization | 1.39 Million | 1.19 Million | 1.33 Million | 4.44 Million | 945 Thousand | 1.08 Million |
| Deferred income taxes | - | - | -87.61 Million | -104.23 Million | - | - |
| Stock-based compensation | 4.04 Million | 3.57 Million | 3.04 Million | 11.15 Million | 2.87 Million | 2.67 Million |
| Change in working capital | -27.41 Million | 67.2 Million | -84.87 Million | -66.55 Million | 2.81 Million | 17.54 Million |
| Other non-cash items | 12.13 Million | -81.91 Million | 85.86 Million | 100.78 Million | -1.78 Million | 72 Thousand |
| Investing Cash Flow | -35.94 Million | -96.06 Million | 26.83 Million | -141.64 Million | -158.3 Million | -24.66 Million |
| Investments in PPE | -967 Thousand | -2.14 Million | -755 Thousand | -3.25 Million | -782 Thousand | -1.21 Million |
| Acquisitions | - | - | -27.58 Million | 138.38 Million | 157.52 Million | 23.45 Million |
| Investment purchases | -90 Million | -203.85 Million | -28.99 Million | -223.96 Million | -166.52 Million | -28.45 Million |
| Sales/Maturities of investments | 55.03 Million | 109.92 Million | 56.58 Million | 85.58 Million | 9 Million | 5 Million |
| Other Investing Activities | -34.97 Million | -93.92 Million | 27.58 Million | -138.38 Million | -157.52 Million | -23.45 Million |
| Financing Cash Flow | 571 Thousand | 112.85 Million | 2.56 Million | 33.64 Million | 331 Thousand | 1.54 Million |
| Debt repayment | - | - | -2.1 Million | - | -2.1 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 19.3 Million | - | - | - | - |
| Common Stock Issuance | 571 Thousand | 112.85 Million | 460 Thousand | 33.64 Million | 331 Thousand | 1.54 Million |
| Other Financing Activities | 571 Thousand | 112.85 Million | 4.2 Million | 33.64 Million | 2.1 Million | 1.54 Million |
| Accounts receivables | 206 Thousand | 80.03 Million | -80.23 Million | -83.23 Million | 97 Thousand | 21.97 Million |
| Accounts payables | -4.97 Million | 5.97 Million | -1.66 Million | -962 Thousand | 1.61 Million | -2.03 Million |
| Inventory | - | - | - | - | 2.06 Million | -893 Thousand |
| Other working capital | -22.64 Million | -18.8 Million | -2.97 Million | 17.63 Million | -962 Thousand | -1.5 Million |
| Cash at beginning of period | 143.07 Million | 68.8 Million | 65.26 Million | 98.95 Million | 245.88 Million | 269.83 Million |
| Cash at end of period | 76.12 Million | 143.07 Million | 68.8 Million | 68.8 Million | 66.86 Million | 245.88 Million |
| Capital Expenditure | -967 Thousand | -2.14 Million | -755 Thousand | -3.25 Million | -782 Thousand | -1.21 Million |
| Effect of forex changes on cash | - | - | - | -78 Thousand | - | - |
| Net cash flow / Change in cash | -66.95 Million | 74.27 Million | 3.53 Million | -30.15 Million | -179.02 Million | -23.95 Million |
| Free Cash Flow | -32.54 Million | 56.62 Million | -26.61 Million | 74.66 Million | -21.83 Million | -2.04 Million |
1894
CENTUM
CEU
5303
FJTCY
COF-PN